Constellation Pharmaceuticals

$23.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.18 (+0.79%) Today
$0.00 (0.00%) As of 7:11 AM EDT after-hours

Why Robinhood?

You can buy or sell CNST and other stocks, options, and ETFs commission-free!

About CNST

Constellation Pharmaceuticals, Inc. Common Stock, also called Constellation Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. Read More The company utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product candidates include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. The listed name for CNST is Constellation Pharmaceuticals, Inc. Common Stock.

Employees
106
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
1.09B
Price-Earnings Ratio
Dividend Yield
Average Volume
379.31K
High Today
$23.20
Low Today
$21.98
Open Price
$22.94
Volume
321.55K
52 Week High
$59.49
52 Week Low
$11.66

Collections

CNST Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Oct 29, Pre-Market

You May Also Like